INFORMATION FOR THE CONSUMER

Similar documents
Medication Guide Fentanyl transdermal system, CII Rx Only Fentanyl transdermal system is: A strong prescription pain medicine that contains an opioid

PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)

Medication Guide Fentanyl Transdermal System, CII (fĕn tə-nĭl) Fentanyl transdermal system is:

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

CONSUMER MEDICINE INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRANSDERM-NITRO nitroglycerin patch

Transiderm-Nitro 5 milligrams/24 hours, Transiderm-Nitro10 milligrams/24 hours and Transiderm-Nitro15 milligrams/24 hours Transdermal patch

Package leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection

PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)

Patient Information. Sancuso [san-koo-so] (granisetron transdermal system)

BrinzoQuin Eye Drops 1.0%

Tell your doctor if you have ever abused or been dependent on alcohol, prescription medicine or street drugs.

NEVANAC TM 0.1% Eye Drops

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

FIRAZYR Icatibant acetate

Eloxatin Oxaliplatin concentrated solution for injection

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

ZADITEN Eye Drops 1.0%

Guide for Patients & Caregivers

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

LECTOPAM PRODUCT MONOGRAPH. bromazepam. 3 mg and 6 mg Tablets. Anxiolytic - Sedative. Date of Revision: September 6, 2018

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

PATIENT INFORMATION LEAFLET TEXAMER

NicAssist 24 Hour Patch

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

PATIENT INFORMATION LEAFLET. Naseptin Nasal Cream chlorhexidine dihydrochloride and neomycin sulfate

Why do I need to use Fentanyl Patches?

XYZAL 5 MG FILM-COATED TABLET

PACKAGE LEAFLET. Page 1 of 6

MAXIDEX TM Eye Ointment 0.1%

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

PATIENT INFORMATION LEAFLET. DOTAREM mg/ml, solution for injection (Gadoteric acid)

APOHEALTH FAMCICLOVIR ONCE

MAXITROL Eye Ointment

ONBREZ BREEZHALER should only be used to treat COPD.

Elements for a public summary

HERNOVIR 200 mg tablets

Guide for Patients and Caregivers

TREANA 5mg and 10mg Film-coated Tablets

KEEP IT SIMPLE WITH SANCUSO. Prevent chemotherapy induced nausea and vomiting with Sancuso Patch for up to 5 full days3

Beclazone 50, 100, 250 micrograms CFC-Free Inhaler

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

TOBRADEX TM Eye Drops

APOHEALTH Diarrhoea Relief PLUS

MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam

PATIENT INFORMATION INCRUSE ELLIPTA

PACKAGE LEAFLET: INFORMATION FOR THE USER DIAZEPAM 5mg/ 10mgRECTAL SOLUTION

The capsule shell contains hypromellose, purified water, carrageenan, potassium chloride and FDC Yellow 6 (110 Sunset Yellow FCF).

Ceclor CD cefaclor monohydrate sustained release tablets

Package leaflet: Information for the patient. Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate)

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER

IMPORTANT: PLEASE READ

Package leaflet: Information for the user. Atropin Stragen 0.1 mg/ml solution for injection in prefilled syringe.

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

CONSUMER MEDICINE INFORMATION

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Oxybutynin Hydrochloride 3mg Tablets

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

TRANSCRIPT for Lantus SoloSTAR pen injection for your patients

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Dorzolamide 20 mg/ml Eye Drops, Solution

What Maxitrol Eye Drops is used for

Simplotan* tablets Tinidazole (tin-id-azole)

Package leaflet: Information for the patient. Scandonest 3% w/v, Solution for Injection Mepivacaine hydrochloride

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION DIMENHYDRINATE INJECTION USP

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)

Atrovent Metered Aerosol (CFC Free)

It is used to treat or prevent upset stomach and throwing up. What do I need to tell my doctor BEFORE I take this drug?

Nitro-Dur 0.2 mg/h, 0.4 mg/h, 0.6 mg/h Transdermal Patch Glyceryl trinitrate

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. N FENTANYL PATCH Fentanyl Transdermal Patches (Matrix)

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

FDA APPROVED MEDICATION GUIDE

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

IMIPENEM+CILASTATIN RBX

AUGMENTIN is also used to prevent infection from major surgery.

IMPORTANT: PLEASE READ

CIPROXIN HC Ear Drops

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Pregabalin. For the Treatment of Pain

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

Package leaflet: Information for the patient. Eklira Genuair 322 micrograms inhalation powder Aclidinium (aclidinium bromide)

TOBREX TM EYE DROPS and EYE OINTMENT 0.3%

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Medication Guide BELBUCATM (bel-bue-kuh) (buprenorphine) buccal film, CIII BELBUCA is:

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl

Transcription:

INFORMATION FOR THE CONSUMER TRANSDERM-V* and HOW TO USE IT (scopolamine) Transdermal Therapeutic System INTRODUCTION This leaflet is intended to help you understand what TRANSDERM-V* is and how it helps to prevent nausea and vomiting associated with motion sickness in adults. Please read it carefully. If you want to know more or have any questions, please ask your doctor or pharmacist. HOW TRANSDERM-V* PREVENTS MOTION SICKNESS In some people, motion of ships, airplanes, trains, automobiles, and buses increases activity of the nerve fibers of the inner ear, which are part of the body's balance mechanism. The result is motion sickness, which is characterized by dizziness, nausea, and vomiting. A person suffering from motion sickness may experience one, all, or any combination of these symptoms. Scopolamine is an effective medication for the prevention of nausea and vomiting because it reduces the activity of the nerve fibers in the inner ear and acts on the motion sickness centers in the brain. TRANSDERM-V* is a small, flexible adhesive disc. When placed behind the ear, it delivers scopolamine to the skin surface from where it is absorbed into the bloodstream over a prolonged period of up to 3 days. WHAT TRANSDERM-V* CONTAINS The active substance is scopolamine. TRANSDERM-V* contains 1.5 mg active substance scopolamine per patch. The other ingredients are light mineral oil/paraffin, light liquid and polyisobutylene.

THINGS TO BE AWARE OF Although TRANSDERM-V* provides health benefits, certain precautions should be taken before their use and in some situations their use may not be appropriate. Restrictions on Use Do not use TRANSDERM-V* if you are allergic (hypersensitive) to scopolamine or have glaucoma. TRANSDERM-V* should not be used in children. The safety of its use in children has not been determined. Children are particularly sensitive to the effects of scopolamine. WARNINGS and PRECAUTIONS Talk to your doctor or pharmacist before using TRANSDERM-V*, if you are pregnant or plan to become pregnant while using this medicine have any obstructions of the stomach or intestines have trouble urinating due to prostrate enlargement or any bladder obstruction are an elderly patient or have any metabolic, liver, or kidney disease have or have had pain in the eyes, blurred vision, or see rainbow-coloured halos around lights(transderm-v*, should only be used after an eye examination by a doctor). have a history of skin allergy or hypersensitivity to any other substance have or have had epilepsy or epileptic seizures (increased number of fits have been reported). taking any other medicines or remedies, as there are some medicines which may affect how TRANSDERM-V* works Any of these conditions could make TRANSDERM-V* unsuitable for you. Breastfeeding women should not take this medicine. Elderly patients should also consult their doctor before using TRANSDERM-V* as they may be particularly sensitive to the effects of scopolamine. Avoid drinking alcohol while using TRANSDERM-V*.

Care should be taken after removing the patch, as side-effects may persist for up to 24 hours or longer. Remove patch before medical scans. Be careful about driving, performing any activity that requires concentration, or operating any machinery while using the system because the drug might make you feel drowsy, confused, dizzy, or may affect your vision. Taking other medicines with TRANSDERM-V*. Tell your doctor or pharmacist if you are taking or have recently taken or want to start taking any other medicines, including medicines obtained without a prescription. In particular, tell your doctor if you are taking any of the following medicines, because TRANSDERM-V* may interact with them: alcohol other drugs acting on brain antiallergic medicines antidepressants antiparkinsons and antivirals antiarrhythmics other travel sickness medicines POSSIBLE SIDE EFFECTS Like all medicines, along with its helpful effects, TRANSDERM-V* may cause unwanted side effects. It is wise to be aware of them so that if they do occur you can report them to your doctor. STOP using TRANSDERM-V* and seek medical help immediately if you have any of the following which may be signs of an allergic reaction: difficulty in breathing or swallowing swelling of the face, lips, tongue or throat severe itching of the skin, with a red rash or raised bumps

Some side effects could be serious which are very rare (may affect 1 in every 10,000 people) changes in vision with increased pressure in the eye (possible signs of glaucoma) If you experience this, tell your doctor straight away. Some side effects are very common (may affect more than 1 in 10 people) dryness of the mouth drowsiness, dizziness blurring of (near) vision and enlargement of the pupils (sometimes in one eye only) loss of ability to focus on close or far objects (visual accommodation) Some side effects are common (may affect between 1 and 10 in every 100 people) irritation of the eyelids skin irritation Some side effects are rare (may affect between 1 and 10 in every 10,000 people) difficulty in urinating impairment of memory or concentration, restlessness, disorientation, confusion, or hallucinations slight decrease in blood pressure Some side effects are very rare (may affect less than 1 in every 10,000 people) skin rash Other side effects (unknown frequency) application site burning If you get any side effects which worry you (even effects not listed in this leaflet) remove the patch and talk to your doctor or pharmacist. Eye Effects: Temporary blurring of vision and dilation (widening) of the pupils may occur, especially if traces of the drug are on your fingers or hands and come in contact with your eyes. Dry, itchy, or reddened whites of the eye and eye pain have been reported infrequently. In the unlikely event that you experience pain in the eye and reddened whites of the eye, which may be accompanied by widening of the pupil and blurred vision, remove the disc and consult your physician promptly. Widening of the

pupils and blurred vision without pain or reddened whites of the eye is usually temporary and not serious. Possible Effects After Removing the Disc: There have been complaints of transient dizziness, nausea (feeling sick), vomiting (being sick), headache, and disturbances of balance following discontinuation of TRANSDERM-V*. If this happens, please consult a doctor. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. DOSAGE Only one TRANSDERM-V* disc can be used at any one time. Each disc may be worn for a maximum period of 3 days. Treatment with TRANSDERM-V* must not exceed six days, i.e. one disc worn for 3 days followed by a new disc worn for a second 3 days. Apply one TRANSDERM-V* disc on the hairless area behind one ear approximately 12 hours before the drug's anti-nausea and anti-vomiting effect is needed. The disc may be worn for up to 3 days, and then it should be removed. If the disc is only needed for a shorter time, it should be removed at the end of the journey. If you wish to control nausea for longer than 3 days, a second disc should be placed on a different skin site behind the other ear. The second disc may be worn for up to 3 days if needed. Discontinue using TRANSDERM-V* once the second disc has been worn for 3 days. HOW TO USE TRANSDERM-V* 1. Select a non-hairy area of skin on the head behind the ear, taking care to avoid a site containing any cuts or irritations. Wipe the area with a clean, dry tissue. 2. Each TRANSDERM-V* disc is individually sealed in a protective foil pouch. Before removing the disc from its pouch, be sure to wash your hands with soap and water. 3. Peel the foil pouch open and remove the tan-coloured disc complete with its clear plastic six-sided protective liner (Figure 1).

Figure 1 4. Holding the disc only by its edge - and taking care not to touch the adhesive surface (metallic side) with your hands - peel off the clear plastic protective liner. (Figure 2) Figure 2 system disposable backing 5. Firmly apply the adhesive surface (metallic side) of the disc to the dry area of skin behind the ear so that the tan-coloured side is showing (Figure 3). Press firmly to make good contact especially around the edge. Once you have placed the disc behind your ear, do not touch it for the duration of desired use. Figure 3 tan colored system 6. Important: Be sure to wash your hands thoroughly with soap and water immediately after handling the disc, so that any drug that might get on your hands will not come into contact with your eyes (see Possible Side Effects). 7. Remove the disc after 3 days and carefully dispose of it. (You may remove it sooner if you are no longer concerned about motion sickness.) After removing the disc, be sure to wash your hands and the application site. 8. If you wish to control nausea for longer than 3 days, remove the first disc after 3 days and place a new disc on a different skin site behind the other ear. Use the same procedures and precautions described above. Discontinue using TRANSDERM-V* once the second disc has been worn for a maximum of 3 days. 9. Limited contact with water, as in bathing or swimming, will not affect the functioning of the disc. It is preferable, however, to keep the disc dry to prevent it from falling off.

In the unlikely event that the disc falls off, carefully discard it and put a new one behind the other ear. IF YOU USE MORE TRANSDERM-V* THAN YOU SHOULD If you accidentally apply too many patches at the same time, you may feel restless, excited or confused. In cases of higher overdose, you may become disorientated, hallucinate or have fits. In severe cases of overdose, coma and breathing difficulties may occur. Remove the patch/patches immediately (as some overdose symptoms may persist for up to 24 hours or longer even after patch removal), and tell your doctor or contact your nearest casualty department immediately. Take any remaining patches with you. STORAGE TRANSDERM-V* should be stored at temperatures below 25 C. Do not freeze. Do not store it out of the individually sealed pouch. TRANSDERM-V* should be kept out of the reach of children and pets both before and after use. If your disc becomes stuck to a child or another person, remove the disc at once and contact a doctor. The transdermal patch should be folded in half (sticky side inwards) before being discarded. Do not dispose of medicines via wastewater or household waste. Novartis Pharmaceuticals Canada Inc. 385 Bouchard Boulevard Dorval, Quebec H9S 1A9 *TRANSDERM-V is a registered trademark of Novartis Pharmaceuticals Canada Inc.